COPDBreakthrough in COPD treatmentLatest NewsFrench Sanofi SAs second Phase III trial of duplimab demonstrated a 34% reduction in exacerbations and significant lung function improvements. Read more 27 November 2023 https://european-biotechnology.com/wp-content/uploads/2024/04/RS3431_tk1-2_2015_8043745300_cda27ab29f_o.jpg 991 1920 Margarita Milidakis /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Margarita Milidakis2023-11-27 11:09:082024-07-09 12:51:28Breakthrough in COPD treatment